Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

BACKGROUND: The prognostic impact of increased beta-2 microglobulin (B2M) in patients with light chain (AL) amyloidosis undergoing autologous stem cell transplantation (ASCT) is unknown. The Mayo 2012 stage and increased bone marrow plasma cell (BMPC) percentage are known predictors for survival. In...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Al Saleh, Abdullah S., Sidiqi, M Hasib, Muchtar, Eli, Buadi, Francis K., Dispenzieri, Angela, Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Kourelis, Taxiarchis V., Hogan, William J., Hayman, Suzanne R., Kapoor, Prashant, Kumar, Shaji K., Gertz, Morie A.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371505/
https://ncbi.nlm.nih.gov/pubmed/32422250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.04.024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares